Shanghai Fochon Pharmaceutical Co., Ltd.

Chongqing Fochon Pharmaceutical Co., Ltd.

Fochon Pharmaceuticals, Ltd.

Chinese Academy of Sciences

Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Fochon Biosciences, Ltd.

Fochon Pharmaceutical Co., Ltd.

Lihua Jiang

Weibo Wang

Xingdong Zhao

Xianlong Wang

Zuwen Zhou

Yanxin Liu

Haohan Tan

Jing Sun

Tongshuang Li

Zhifu Li

Zhifang Chen

Yue Rong

Ling Chen

Qihong Liu

Rui Tan

Qiang Tian

Hongbin Liu

Huajie Zhang

Chengxi He

Li Linghu

Fanxin Zeng

Min Lin

Weipeng Zhang

Lijun Yang

Zongyao Zou

Kai Ran

Quan Yuan

Hailong Shi

Bo Fang

Jiemin Fu

Jian Ding

Meiyu Geng

Linghua Meng

Bin Liu

Shu Lin

Yuwei Gao

Chuiliang Yu

Provided are certain Bcl-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Apoptosis-inducing agents

Provided are certain TRK inhibitors of formula (I): pharmaceutical compositions thereof, and methods of use thereof.

Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors

Bcl-2 inhibitors, pharmaceutical compositions thereof, and methods of use thereof are provided. In particular, Bcl-2 inhibitors of formula (I) are provided, wherein the variable groups are as defined in the specification. The Bcl-2 inhibitors can be used to treat cell proliferative disorders. 

Compounds as BLC-2-selective apoptosis-inducing agents

Provided are certain CDK4/6 inhibitors with the structure of formula (I), pharmaceutical compositions thereof, and methods of use therefor. The compounds are of the class of pyrimidin-2 amine derivatives, useful for the treatment of hyper-proliferative diseases. 

Certain protein kinase inhibitor

Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Certain protein kinase inhibitors

Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof. 

Disclosed herein are protein kinase inhibitors, more particularly novel quinazoline derivatives and pharmaceutical compositions thereof, and method of use thereof.

Quinazoline derivatives, compositions thereof, and use as pharmaceuticals

Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Growing community of inventors

Chongqing, China

Lihua Jiang